Matthew F. Mescher

8.6k total citations · 1 hit paper
86 papers, 6.9k citations indexed

About

Matthew F. Mescher is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Matthew F. Mescher has authored 86 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Immunology, 19 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Matthew F. Mescher's work include T-cell and B-cell Immunology (58 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (46 papers). Matthew F. Mescher is often cited by papers focused on T-cell and B-cell Immunology (58 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (46 papers). Matthew F. Mescher collaborates with scholars based in United States, Croatia and Russia. Matthew F. Mescher's co-authors include Julie Curtsinger, Debra C. Lins, Clint S. Schmidt, Protul Shrikant, Javier O. Valenzuela, Matthew J. Deeths, Anne M. O’Rourke, Kerry A. Casey, Ross M. Kedl and Zhengguo Xiao and has published in prestigious journals such as Nature, Science and The Journal of Experimental Medicine.

In The Last Decade

Matthew F. Mescher

86 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation

2005 504 citations Julie Curtsinger, Javier O. Valenzuela et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew F. Mescher United States	43	5.7k	1.8k	1.3k	475	418	86	6.9k
Bénédita Rocha France	45	7.4k 1.3×	1.4k 0.8×	1.0k 0.8×	545 1.1×	437 1.0×	109	8.6k
Robert S. Mittler United States	50	6.4k 1.1×	2.6k 1.4×	1.5k 1.2×	489 1.0×	746 1.8×	105	8.2k
Franca Ronchese New Zealand	43	4.4k 0.8×	1.2k 0.7×	1.3k 1.0×	399 0.8×	291 0.7×	118	5.9k
Gilles Uzé France	41	4.3k 0.7×	2.8k 1.5×	1.6k 1.2×	852 1.8×	580 1.4×	75	6.4k
Robert E. Tigelaar United States	46	5.2k 0.9×	1.2k 0.7×	864 0.7×	557 1.2×	394 0.9×	97	6.9k
David H. Presky United States	33	4.3k 0.8×	1.4k 0.8×	1.1k 0.9×	776 1.6×	406 1.0×	53	6.1k
Lélia Delamarre United States	28	3.9k 0.7×	1.5k 0.8×	2.0k 1.5×	427 0.9×	379 0.9×	50	5.4k
Russell D. Salter United States	36	4.3k 0.8×	760 0.4×	2.2k 1.7×	561 1.2×	625 1.5×	75	6.3k
Masaki Terabe United States	42	4.7k 0.8×	2.4k 1.3×	1.6k 1.2×	650 1.4×	198 0.5×	101	6.5k
Anneliese Schimpl Germany	37	4.3k 0.7×	815 0.4×	1.4k 1.1×	511 1.1×	462 1.1×	96	6.0k

Countries citing papers authored by Matthew F. Mescher

Since Specialization

Citations

This map shows the geographic impact of Matthew F. Mescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew F. Mescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew F. Mescher more than expected).

Fields of papers citing papers by Matthew F. Mescher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew F. Mescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew F. Mescher. The network helps show where Matthew F. Mescher may publish in the future.

Co-authorship network of co-authors of Matthew F. Mescher

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew F. Mescher. A scholar is included among the top collaborators of Matthew F. Mescher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew F. Mescher. Matthew F. Mescher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dings, Ruud P.M., Kieng B. Vang, Karolien Castermans, et al.. (2011). Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer. Clinical Cancer Research. 17(10). 3134–3145. 59 indexed citations

Xiao, Zhengguo, Kerry A. Casey, Stephen C. Jameson, Julie Curtsinger, & Matthew F. Mescher. (2009). Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN. The Journal of Immunology. 182(5). 2786–2794. 169 indexed citations

Gerner, Michael Y. & Matthew F. Mescher. (2009). Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells. The Journal of Immunology. 182(5). 2726–2737. 36 indexed citations

Gerner, Michael Y., Kerry A. Casey, & Matthew F. Mescher. (2008). Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses. The Journal of Immunology. 181(1). 155–164. 54 indexed citations

Mescher, Matthew F., Julie Curtsinger, Kerry A. Casey, et al.. (2006). Signals required for programming effector and memory development by CD8⁺ T cells. Immunological Reviews. 211(1). 81–92. 476 indexed citations

Curtsinger, Julie, Debra C. Lins, Christopher M. Johnson, & Matthew F. Mescher. (2005). Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis. The Journal of Immunology. 175(7). 4392–4399. 70 indexed citations

Curtsinger, Julie, et al.. (2005). Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation. The Journal of Immunology. 174(8). 4465–4469. 504 indexed citations breakdown →

Mitchell, Malcolm S., et al.. (2004). Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma. Clinical Cancer Research. 10(1). 76–83. 26 indexed citations

Shrikant, Protul, et al.. (2003). In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen). The Journal of Immunology. 170(1). 228–235. 46 indexed citations

10.

Curtsinger, Julie, Christopher M. Johnson, & Matthew F. Mescher. (2003). CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine. The Journal of Immunology. 171(10). 5165–5171. 221 indexed citations

11.

Schmidt, Clint S. & Matthew F. Mescher. (2002). Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-12. The Journal of Immunology. 168(11). 5521–5529. 110 indexed citations

12.

Ingulli, Elizabeth, Julie Curtsinger, Clint S. Schmidt, et al.. (2002). The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo. The Journal of Immunology. 169(10). 5622–5629. 46 indexed citations

13.

Shrikant, Protul, et al.. (2002). Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response. The Journal of Immunology. 168(3). 1190–1197. 71 indexed citations

14.

Kieper, William C., Martin Prlic, Clint S. Schmidt, Matthew F. Mescher, & Stephen C. Jameson. (2001). IL-12 Enhances CD8 T Cell Homeostatic Expansion. The Journal of Immunology. 166(9). 5515–5521. 99 indexed citations

15.

Mescher, Matthew F., et al.. (2001). Signaling Alterations in Activation-Induced Nonresponsive CD8 T Cells. The Journal of Immunology. 167(4). 2040–2048. 36 indexed citations

16.

Shrikant, Protul, Alexander Khoruts, & Matthew F. Mescher. (1999). CTLA-4 Blockade Reverses CD8+ T Cell Tolerance to Tumor by a CD4+ T Cell– and IL-2-Dependent Mechanism. Immunity. 11(4). 483–493. 248 indexed citations

17.

Curtsinger, Julie, Clint S. Schmidt, Anna Mondino, et al.. (1999). Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells. The Journal of Immunology. 162(6). 3256–3262. 471 indexed citations

18.

Curtsinger, Julie, Debra C. Lins, & Matthew F. Mescher. (1998). CD8+ Memory T Cells (CD44high, Ly-6C+) Are More Sensitive than Naive Cells (CD44low, Ly-6C−) to TCR/CD8 Signaling in Response to Antigen. The Journal of Immunology. 160(7). 3236–3243. 150 indexed citations

19.

O’Rourke, Anne M., et al.. (1993). CD8 and antigen-specific T cell adhesion cascades. Seminars in Immunology. 5(4). 263–270. 5 indexed citations

20.

O’Rourke, Anne M., J Rogers, & Matthew F. Mescher. (1990). Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling. Nature. 346(6280). 187–189. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact